111 related articles for article (PubMed ID: 12045447)
1. In-111 octreotide uptake in the thymus in a patient with Cushing's syndrome.
Duarte PS; Zhuang H; Gusmao Mde L; Liberman B
Clin Nucl Med; 2002 Jun; 27(6):453-4. PubMed ID: 12045447
[No Abstract] [Full Text] [Related]
2. Recurrent ectopic adrenocorticotropic hormone producing thymic carcinoid detected with octreotide imaging.
Silva F; Vázquez-Sellés J; Aguilö F; Vázquez G; Flores C
Clin Nucl Med; 1999 Feb; 24(2):109-10. PubMed ID: 9988068
[TBL] [Abstract][Full Text] [Related]
3. [Cushing's syndrome secondary to bronchial carcinoid tumor: contribution of gammagraphy with 111In-DTPA octreotide in the localization diagnosis].
Peña González E; Lampreave Márquez JL; León Atance P; Moreno Esteban B; Bittini Copano A; Folqué Gómez E
An Med Interna; 1999 Nov; 16(11):577-9. PubMed ID: 10637999
[TBL] [Abstract][Full Text] [Related]
4. Radiologic-Pathologic Correlation Conference: SUNY Upstate Medical Center. Cushing syndrome associated with mediastinal mass.
Felson B; Castleman B; Levinsohn EM; Markarian B
AJR Am J Roentgenol; 1982 May; 138(5):815-9. PubMed ID: 6979168
[No Abstract] [Full Text] [Related]
5. [Gammagraphy of somatostatin receptors in an ACTH secreting thymic carcinoid].
Banzo J; Razola P; Prats E; Freile E; Benito JL; García López F; García Tirado J; Abós MD
Rev Esp Med Nucl; 1999; 18(2):99-103. PubMed ID: 10352322
[TBL] [Abstract][Full Text] [Related]
6. Indium-111 pentetreotide imaging of carcinoid tumor of the thymus.
Borrero CG; McCook B; Mountz JM
Clin Nucl Med; 2005 Apr; 30(4):218-21. PubMed ID: 15764874
[TBL] [Abstract][Full Text] [Related]
7. Ectopic ACTH syndrome due to occult bronchial carcinoid.
Corsello SM; Fintini D; Lovicu RM; Paragliola RM; Rufini V; Simonetti G; Pontecorvi A
Clin Nucl Med; 2009 Jul; 34(7):459-61. PubMed ID: 19542957
[No Abstract] [Full Text] [Related]
8. Computed tomography appearance of the thymus and anterior mediastinum in active Cushing's syndrome.
Hanson JA; Sohaib SA; Newell-Price J; Islam N; Monson JP; Trainer PJ; Grossman A; Besser GM; Reznek RH
J Clin Endocrinol Metab; 1999 Feb; 84(2):602-5. PubMed ID: 10022423
[TBL] [Abstract][Full Text] [Related]
9. The radiological investigation of occult ectopic ACTH-dependent Cushing's syndrome.
Vincent JM; Trainer PJ; Reznek RH; Marcus AJ; Dacie JE; Armstrong P; Besser GM
Clin Radiol; 1993 Jul; 48(1):11-7. PubMed ID: 8396521
[TBL] [Abstract][Full Text] [Related]
10. A Pulmonary adrenocorticotropin-secreting carcinoid tumor localized by 6-Fluoro-[18F]L-dihydroxyphenylalanine positron emission/computed tomography imaging in a patient with Cushing's syndrome.
Dubois S; Morel O; Rodien P; Illouz F; Girault S; Cahouet A; Lacoeuille F; Brousseau M; Picquet J; Rohmer V
J Clin Endocrinol Metab; 2007 Dec; 92(12):4512-3. PubMed ID: 18056777
[No Abstract] [Full Text] [Related]
11. The role of computed tomography in a case of an ACTH secreting thymic carcinoid tumour.
Fitzgerald PM; Rickard MT; Martin GE
Comput Radiol; 1982; 6(4):209-14. PubMed ID: 6291848
[No Abstract] [Full Text] [Related]
12. Cushing's syndrome associated with a chemodectoma and a carcinoid tumour.
Tremble JM; Buxton-Thomas M; Hopkins D; Kane P; Bailey D; Harris PE
Clin Endocrinol (Oxf); 2000 Jun; 52(6):789-93. PubMed ID: 10848885
[TBL] [Abstract][Full Text] [Related]
13. Ectopic Cushing's syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe1]octreotide.
Matte J; Roufosse F; Rocmans P; Schoutens A; Jacobovitz D; Mockel J
Postgrad Med J; 1998 Feb; 74(868):108-10. PubMed ID: 9616493
[TBL] [Abstract][Full Text] [Related]
14. Imaging of a mediastinal thymic carcinoid tumor with radiolabeled somatostatin analogue.
Cadigan DG; Hollett PD; Collingwood PW; Ur E
Clin Nucl Med; 1996 Jun; 21(6):487-8. PubMed ID: 8744192
[No Abstract] [Full Text] [Related]
15. Somatostatin receptor scintigraphy in carcinoids, gastrinomas and Cushing's syndrome.
Krenning EP; Kwekkeboom DJ; Oei HY; de Jong RJ; Dop FJ; de Herder WW; Reubi JC; Lamberts SW
Digestion; 1994; 55 Suppl 3():54-9. PubMed ID: 7698538
[TBL] [Abstract][Full Text] [Related]
16. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
Lastoria S; Vergara E; Palmieri G; Acampa W; Varrella P; Caracò C; Bianco RA; Muto P; Salvatore M
J Nucl Med; 1998 Apr; 39(4):634-9. PubMed ID: 9544670
[TBL] [Abstract][Full Text] [Related]
17. Adrenal hyperplasia in Cushing's syndrome demonstrated by FDG positron emission tomographic imaging.
Lin EC; Helgans R
Clin Nucl Med; 2002 Jul; 27(7):516-7. PubMed ID: 12072780
[No Abstract] [Full Text] [Related]
18. [Thymic carcinoid tumor revealed by a Cushing's syndrome: usefulness of positron emission tomography].
Gomard-Mennesson E; Sève P; De La Roche E; Collardeau-Frachon S; Lombard-Bohas C; Broussolle C
Rev Med Interne; 2008 Sep; 29(9):751-3. PubMed ID: 18304700
[TBL] [Abstract][Full Text] [Related]
19. [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome.
Markou A; Manning P; Kaya B; Datta SN; Bomanji JB; Conway GS
Eur J Endocrinol; 2005 Apr; 152(4):521-5. PubMed ID: 15817906
[TBL] [Abstract][Full Text] [Related]
20. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
